{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhang W"],"funding":["American Cancer Society","Division of Electrical, Communications and Cyber Systems","International Institute of Nanotechnology","American Committee for the Weizmann Institute of Science","National Cancer Institute","State of Illinois","NCI NIH HHS","Lefkofsky Family Foundation"],"pagination":["46325-46333"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8590845"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(39)"],"pubmed_abstract":["Liposomal spherical nucleic acids (LSNAs) modified with polyethylene glycol (PEG) units are studied in an attempt to understand how the circulation time and biodistribution of the constructs can be manipulated. Specifically, the effect of (1) PEG molecular weight, (2) PEG shell stability, and (3) PEG modification method (PEG in both the core and shell versus PEG in the shell only) on LSNA blood circulation, biodistribution, and <i>in vivo</i> cell internalization in a syngeneic, orthotopic triple-negative breast cancer mouse model is studied. Generally, high PEG molecular weight extends blood circulation lifetime, and a more lipophilic anchor stabilizes the PEG shell and improves circulation and tumor accumulation but at the cost of cell uptake efficiency. The PEGylation strategy has a min"],"journal":["ACS applied materials & interfaces"],"pubmed_title":["Controlling the Biological Fate of Liposomal Spherical Nucleic Acids Using Tunable Polyethylene Glycol Shells."],"pmcid":["PMC8590845"],"funding_grant_id":["U54CA199091","P50 CA221747","ECCS-2025633","P30 CA060553","R01 CA208783","PF-20-046-01 - LIB","P30-CA060553","P50CA221747","CA060553","U54 CA199091","R01CA208783"],"pubmed_authors":["Zhang W","Mirkin CA","Callmann CE"],"additional_accession":[]},"is_claimable":false,"name":"Controlling the Biological Fate of Liposomal Spherical Nucleic Acids Using Tunable Polyethylene Glycol Shells.","description":"Liposomal spherical nucleic acids (LSNAs) modified with polyethylene glycol (PEG) units are studied in an attempt to understand how the circulation time and biodistribution of the constructs can be manipulated. Specifically, the effect of (1) PEG molecular weight, (2) PEG shell stability, and (3) PEG modification method (PEG in both the core and shell versus PEG in the shell only) on LSNA blood circulation, biodistribution, and <i>in vivo</i> cell internalization in a syngeneic, orthotopic triple-negative breast cancer mouse model is studied. Generally, high PEG molecular weight extends blood circulation lifetime, and a more lipophilic anchor stabilizes the PEG shell and improves circulation and tumor accumulation but at the cost of cell uptake efficiency. The PEGylation strategy has a min","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Oct","modification":"2025-04-26T15:33:54.178Z","creation":"2025-04-06T14:56:30.365Z"},"accession":"S-EPMC8590845","cross_references":{"pubmed":["34547202"],"doi":["10.1021/acsami.1c12852"]}}